| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |